Lack of association between CTLA-4+49A/G and -318C/T polymorphisms and Behcet's disease risk: a meta-analysis

被引:0
作者
Zhang, Y. -J. [1 ,2 ]
Xu, W. -D. [1 ,2 ]
Duan, Z. -H. [1 ]
Liu, S. -S. [1 ,2 ]
Pan, H. -F. [1 ,2 ]
Ye, D. -Q. [1 ,2 ]
机构
[1] Anhui Med Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Hefei 230032, Anhui, Peoples R China
[2] Anhui Med Univ, Anhui Prov Lab Populat Hlth & Major Dis Screening, Hefei 230032, Anhui, Peoples R China
基金
中国国家自然科学基金;
关键词
Behcet's syndrome; CTLA-4; polymorphism; meta-analysis; GENE POLYMORPHISMS; TURKISH PATIENTS; PATHOGENESIS; VARIANTS; INSIGHTS; PROTEIN;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective. To more precisely determine whether there is a significant association of cytotoxic T-lymphocyte-associated antigen 4 (CTLA-4) gene polymorphisms with the susceptibility for Behcet's disease. Methods. Eight studies that included data from 7 articles were identified using PubMed, Embase, Chinese Biomedical Literature Database (CBM), and Chinese National Knowledge Infrastructure (CNKI) published before March 2012. Meta-analysis was performed for two CTLA-4 gene polymorphisms, +49A/G (rs231775) and 318C/T (rs5742909). Statistical analyses were performed using software Review Manager (version 5.1) and Stata (version 11.0). The pooled odds ratio (OR) with 95% confidence interval (95%CI) were presented. Results. Overall, no significant association was detected in all genetic models when all studies were pooled into the meta-analysis (for +49A/G polymorphism: A vs. G, OR=1.173, 95% CI=0.790-1.743; A/A vs. A/G+GIG, OR=1.422, 95% CI-0.718-2.814; A/A+A/G vs. GIG, OR=1.421, 95% CI=0.729-2.767; and for -318C/T polymorphism: C vs. T, OR=1.051, 95% CI=0.844-1.307; C/C vs. T/T+C/T, OR=1.154 95% CI=0.891-1.495, C/C+C/T vs. T/T, OR=1.044, 95% CI=0.301-3.617). Furthermore, in the subgroup analysis by ethnicity, there was also lack of evidence for the association in Turkish patients. Conclusion. Our study failed to provide evidence for the genetic association between CTLA-4 +49A/G and -318C/T polymorphisms with Behcet's disease based on currently available evidence from literature. Further confirmations in large and well-designed studies including other CTLA-4 gene polymorphisms are needed.
引用
收藏
页码:S46 / S50
页数:5
相关论文
共 26 条
[21]  
SILMAN AJ, 1990, LANCET, V335, P1078
[22]   Altered expression of costimulatory molecules in Behcet's disease according to clinical activity [J].
Sim, J. H. ;
Park, M. J. ;
Park, S. ;
Lee, E-S. .
BRITISH JOURNAL OF DERMATOLOGY, 2011, 164 (06) :1285-1291
[23]   LOSS OF CTLA-4 LEADS TO MASSIVE LYMPHOPROLIFERATION AND FATAL MULTIORGAN TISSUE DESTRUCTION, REVEALING A CRITICAL NEGATIVE REGULATORY ROLE OF CTLA-4 [J].
TIVOL, EA ;
BORRIELLO, F ;
SCHWEITZER, AN ;
LYNCH, WP ;
BLUESTONE, JA ;
SHARPE, AH .
IMMUNITY, 1995, 3 (05) :541-547
[24]  
Touma Z, 2008, CLIN EXP RHEUMATOL, V26, pS132
[25]   Behcet's syndrome [J].
Yurdakul, Sebahattin ;
Yazici, Hasan .
BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY, 2008, 22 (05) :793-809
[26]  
Zhao CL, 2008, MOL VIS, V14, P1456